← Back to Search

Intermittent fasting group for Weight Loss

N/A
Waitlist Available
Led By Peter Lemon, PhD
Research Sponsored by University of Western Ontario, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Asymptomatic participants between the ages of 18-30 years with body mass index ˃25 will be studied
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Summary

Participants will complete a one-month intervention where they are will restrict their daily food intake to an 8-hour time period, i.e., between 1200 to 2000 hours. During the remaining 16-hour intermittent fasting period (2000 to 1200 hours) participants will be allowed to drink zero calorie beverages (diet soda pop, black coffee, tea, water, etc) in order to maintain normal hydration. There will be no attempt to restrict food intake. Rather simply to restrict the time period each day when food is consumed. Participants' body mass, fat mass, and non-fat mass will be monitored non-invasively using a weigh scale and densitometry via air displacement (Bod Pod) at 0, 2 and 4 weeks following the dietary intervention. Also, participants will be interviewed following the final body composition measure to assess whether or not they continued to follow the intermittent fasting approach.

Eligible Conditions
  • Weight Loss

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fat mass change over 4 weeks period of intervention
Secondary study objectives
Blood sugar change over 4 weeks of intervention
Diet satisfaction change over 4 weeks of intervention
Feeling of fullness change over 4 weeks of intervention
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intermittent fasting groupExperimental Treatment1 Intervention
Participants will restrict their daily food intake (time restricted feeding) to an 8-hour time period between 1200 to 2000 hours. During the remaining 16-hour intermittent fasting period (2000 to 1200 hours) participants will be allowed to drink zero calorie beverages (diet soda pop, black coffee, tea, water, etc) in order to maintain normal hydration. There will be no attempt to restrict food intake. Rather simply to restrict the time period each day when food is consumed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time restricted feeding
2019
Completed Phase 2
~910

Find a Location

Who is running the clinical trial?

University of Western Ontario, CanadaLead Sponsor
164 Previous Clinical Trials
319,222 Total Patients Enrolled
1 Trials studying Weight Loss
16 Patients Enrolled for Weight Loss
Peter Lemon, PhDPrincipal InvestigatorWestern University
14 Previous Clinical Trials
351 Total Patients Enrolled
2 Trials studying Weight Loss
66 Patients Enrolled for Weight Loss
~2 spots leftby Sep 2025